{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T13:58:43Z","timestamp":1764079123099},"reference-count":20,"publisher":"Impact Journals, LLC","issue":"31","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,10,13]]},"DOI":"10.18632\/oncotarget.5208","type":"journal-article","created":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T21:54:23Z","timestamp":1443563663000},"page":"31030-31038","source":"Crossref","is-referenced-by-count":14,"title":["Transcriptome analysis indicates TFEB1 and YEATS4 as regulatory transcription factors for drug resistance of ovarian cancer"],"prefix":"10.18632","volume":"6","author":[{"given":"Yi Rang","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Hemato-Oncology, Yuseong Sun Hospital, Daejeon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi Sung","family":"Park","sequence":"additional","affiliation":[{"name":"Institute for Metabolic Disease, School of Medicine, Wonkwang University, Iksan, Jeonbuk, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki Hwan","family":"Eum","sequence":"additional","affiliation":[{"name":"Wonkwang Institute of Interfused Biomedical Science and Dental Research Institute, School of Dentistry, Wonkwang University, Iksan, Chonbuk, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juhee","family":"Kim","sequence":"additional","affiliation":[{"name":"Wonkwang Institute of Interfused Biomedical Science and Dental Research Institute, School of Dentistry, Wonkwang University, Iksan, Chonbuk, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Won","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Samsung Medical Center and Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taejeong","family":"Bae","sequence":"additional","affiliation":[{"name":"Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae Ho","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Wonkwang University School of Medicine and Hospital, Iksan, Jeonbuk, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Woo","family":"Choi","sequence":"additional","affiliation":[{"name":"Wonkwang Institute of Interfused Biomedical Science and Dental Research Institute, School of Dentistry, Wonkwang University, Iksan, Chonbuk, Republic of Korea"},{"name":"Advanced Institute of Convergence Technology, Seoul National University Suwon Gyeonggi-do, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2015,8,17]]},"reference":[{"key":"1","first-page":"1053","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Journal of experimental & clinical cancer research"},{"key":"2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls","volume":"371","author":"Reeves","year":"2008","journal-title":"Lancet"},{"key":"3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1756-9966-31-14","article-title":"Therapeutic strategies in epithelial ovarian cancer","volume":"31","author":"Enomoto","year":"2012","journal-title":"Journal of experimental & clinical cancer research : CR"},{"key":"4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1158\/1535-7163.MCT-08-0986","article-title":"Ixabepilone: targeting betaIII-tubulin expression in taxane-resistant malignancies","volume":"8","author":"Lee","year":"2009","journal-title":"Molecular cancer therapeutics"},{"key":"5","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1124\/pr.111.005637","article-title":"Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes","volume":"64","author":"Gottesman","year":"2012","journal-title":"Pharmacological reviews"},{"key":"6","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.addr.2013.08.004","article-title":"Nanopreparations to overcome multidrug resistance in cancer","volume":"65","author":"Torchilin","year":"2013","journal-title":"Advanced drug delivery reviews"},{"key":"7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1757-2215-4-21","article-title":"Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin","volume":"4","author":"Morin","year":"2011","journal-title":"Journal of ovarian research"},{"key":"8","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature08712","article-title":"The transcriptional network for mesenchymal transformation of brain tumours","volume":"463","author":"Iavarone","year":"2010","journal-title":"Nature"},{"key":"9","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nrc906","article-title":"Transcription factors as targets for cancer therapy","volume":"2","author":"Darnell","year":"2002","journal-title":"Nature reviews Cancer"},{"key":"10","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1128\/MCB.02185-05","article-title":"GAS41 is required for repression of the p53 tumor suppressor pathway during normal cellular proliferation","volume":"26","author":"Roeder","year":"2006","journal-title":"Molecular and cellular biology"},{"key":"11","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/emmm.201202176","article-title":"Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease","volume":"5","author":"Raben","year":"2013","journal-title":"EMBO molecular medicine"},{"key":"12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/bjc.2012.217","article-title":"Identification of differentially expressed genes according to chemosensitivity in advanced ovarian serous adenocarcinomas: expression of GRIA2 predicts better survival","volume":"107","author":"Kim","year":"2012","journal-title":"British journal of cancer"},{"key":"13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Shih Ie","year":"2010","journal-title":"The American journal of surgical pathology"},{"key":"14","doi-asserted-by":"crossref","first-page":"e838","DOI":"10.1038\/cddis.2013.350","article-title":"Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment","volume":"4","author":"Pan","year":"2013","journal-title":"Cell death & disease"},{"key":"15","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1007\/s00018-014-1565-8","article-title":"Novel roles for the MiTF\/TFE family of transcription factors in organelle biogenesis, nutrient sensing, and energy homeostasis","volume":"71","author":"Puertollano","year":"2014","journal-title":"Cellular and molecular life sciences : CMLS"},{"key":"16","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.1174447","article-title":"A gene network regulating lysosomal biogenesis and function","volume":"325","author":"Ballabio","year":"2009","journal-title":"Science"},{"key":"17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrm3565","article-title":"Signals from the lysosome: a control centre for cellular clearance and energy metabolism","volume":"14","author":"Ballabio","year":"2013","journal-title":"Nature reviews Molecular cell biology"},{"key":"18","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1038\/sj.onc.1204650","article-title":"Expression, cellular distribution and protein binding of the glioma amplified sequence (GAS41), a highly conserved putative transcription factor","volume":"20","author":"Meese","year":"2001","journal-title":"Oncogene"},{"key":"19","first-page":"65","article-title":"YEATS domain proteins: a diverse family with many links to chromatin modification and transcription","volume":"87","author":"Kobor","year":"2009","journal-title":"Biochemistry and cell biology = Biochimie et biologie cellulaire"},{"key":"20","doi-asserted-by":"crossref","first-page":"7301","DOI":"10.1158\/0008-5472.CAN-13-1897","article-title":"YEATS4 is a novel oncogene amplified in non-small cell lung cancer that regulates the p53 pathway","volume":"73","author":"Lam","year":"2013","journal-title":"Cancer research"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5208","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T16:56:10Z","timestamp":1589388970000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,17]]},"references-count":20,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2015,10,13]]}},"alternative-id":["5208","26307679"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.5208","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,17]]}}}